Champions Oncolog (CSBR)

$6.58 -0.55 (-7.74%)
Market Cap 101.51M
Revenue (ttm) 56.94M
Net Income (ttm) 4.70M
EPS (ttm) N/A
PE Ratio 43.65
Forward PE N/A
Profit Margin 8.25%
Debt to Equity Ratio 0.00
Volume 6,900
Avg Vol 12,980
Day's Range N/A - N/A
Shares Out 13.89M
Stochastic %K 0%
Beta 0.35
Analysts Strong Sell
Price Target $12.00

Company Profile

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotec...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 808 8400
Address:
One University Plaza, Suite 307, Hackensack, United States
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 29 at 1:54 PM
$CSBR RSI: 69.16, MACD: 0.1474 Vol: 0.31, MA20: 6.95, MA50: 6.76 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Ned__ryerson
Ned__ryerson Jan. 28 at 4:03 AM
$CSBR up big. Volume was light. It wants to pop. Just looking for a reason.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 2 at 7:39 PM
$CSBR RSI: 54.55, MACD: 0.0801 Vol: 0.47, MA20: 6.73, MA50: 6.71 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Hemispheric
Hemispheric Dec. 26 at 12:25 PM
$CSBR Price action signals that reliability now matters more than headline momentum. Efficiency initiatives must translate into measurable productivity. Demonstrated durability would lengthen investor time horizons. Without validation, volatility will remain persistent.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 24 at 11:20 PM
$CSBR Share Price: $7.05 Contract Selected: May 15, 2026 $7.5 Calls Buy Zone: $0.77 – $0.95 Target Zone: $1.32 – $1.61 Potential Upside: 63% ROI Time to Expiration: 141 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Norisknoporsche
Norisknoporsche Dec. 16 at 8:23 AM
$CSBR Earnings yesterday was so bullish
0 · Reply
Delonche
Delonche Dec. 15 at 10:09 PM
$CSBR
0 · Reply
AOB1992
AOB1992 Dec. 15 at 9:22 PM
$CSBR https://www.stocktitan.net/news/CSBR/champions-oncology-reports-record-quarterly-service-revenue-of-14-9-1iivypwxl90n.html Looks like it's a beat!
0 · Reply
AOB1992
AOB1992 Dec. 15 at 9:05 PM
$CSBR bought this as an "earnings play" and it's up already, oh my
0 · Reply
Delonche
Delonche Dec. 15 at 8:45 PM
$CSBR
0 · Reply
Latest News on CSBR
Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript

Dec 15, 2025, 6:09 PM EST - 7 weeks ago

Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript

Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million

Dec 15, 2025, 4:00 PM EST - 7 weeks ago

Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million

Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025

Dec 8, 2025, 4:00 PM EST - 2 months ago

Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025

Champions Oncology, Inc. (CSBR) Q1 2026 Earnings Call Transcript

Sep 15, 2025, 6:35 PM EDT - 5 months ago

Champions Oncology, Inc. (CSBR) Q1 2026 Earnings Call Transcript

CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million

Sep 15, 2025, 4:50 PM EDT - 5 months ago

CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million

Champions Oncology Reports Record Quarterly Revenue of $14.0 Million

Sep 15, 2025, 3:55 PM EDT - 5 months ago

Champions Oncology Reports Record Quarterly Revenue of $14.0 Million

Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025

Sep 10, 2025, 4:30 PM EDT - 5 months ago

Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025

Champions Oncology (CSBR) Q4 2025 Earnings Call Transcript

Jul 25, 2025, 7:55 AM EDT - 6 months ago

Champions Oncology (CSBR) Q4 2025 Earnings Call Transcript

Champions Oncology Reports Record Annual Revenue of $57 Million

Jul 23, 2025, 4:00 PM EDT - 7 months ago

Champions Oncology Reports Record Annual Revenue of $57 Million

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025

Jul 21, 2025, 8:30 AM EDT - 7 months ago

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025

Champions Oncology Announces Appointment of New CEO

Jul 18, 2025, 8:30 AM EDT - 7 months ago

Champions Oncology Announces Appointment of New CEO

Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models

Jul 8, 2025, 8:30 AM EDT - 7 months ago

Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models

Champions Oncology: Biological IP Is The Real Asset - Not Preclinical Services

Jun 16, 2025, 2:47 PM EDT - 8 months ago

Champions Oncology: Biological IP Is The Real Asset - Not Preclinical Services

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House

Apr 28, 2025, 9:45 AM EDT - 10 months ago

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House

Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine

Apr 24, 2025, 8:00 AM EDT - 10 months ago

Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine

Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript

Mar 11, 2025, 8:07 PM EDT - 11 months ago

Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

Mar 11, 2025, 3:55 PM EDT - 11 months ago

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

Mar 6, 2025, 4:00 PM EST - 11 months ago

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting

Feb 18, 2025, 9:00 AM EST - 1 year ago

Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

Jan 8, 2025, 8:00 AM EST - 1 year ago

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies

Dec 27, 2024, 9:00 AM EST - 1 year ago

Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies

Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript

Dec 11, 2024, 6:02 PM EST - 1 year ago

Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million

Dec 11, 2024, 4:00 PM EST - 1 year ago

Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million

Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024

Dec 5, 2024, 4:30 PM EST - 1 year ago

Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024

Champions Oncology Announces Agreement with Weill Cornell Medicine

Oct 16, 2024, 10:55 AM EDT - 1 year ago

Champions Oncology Announces Agreement with Weill Cornell Medicine

Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript

Sep 11, 2024, 8:52 PM EDT - 1 year ago

Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million

Sep 11, 2024, 4:00 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024

Sep 9, 2024, 4:00 PM EDT - 1 year ago

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024

Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript

Jul 18, 2024, 6:11 PM EDT - 1 year ago

Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $14.0 Million

Jul 18, 2024, 4:00 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $14.0 Million

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

Jul 11, 2024, 4:05 PM EDT - 1 year ago

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development

Jun 4, 2024, 9:00 AM EDT - 1 year ago

Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development

Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript

Mar 12, 2024, 7:21 PM EDT - 2 years ago

Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $12.0 Million

Mar 12, 2024, 4:30 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $12.0 Million

Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation

Mar 7, 2024, 9:00 AM EST - 2 years ago

Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024

Mar 6, 2024, 4:35 PM EST - 2 years ago

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024

Champions Oncology, Inc. (CSBR) Q2 2024 Earnings Call Transcript

Dec 12, 2023, 5:54 PM EST - 2 years ago

Champions Oncology, Inc. (CSBR) Q2 2024 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $11.6 Million

Dec 12, 2023, 4:00 PM EST - 2 years ago

Champions Oncology Reports Quarterly Revenue of $11.6 Million

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

Dec 4, 2023, 4:30 PM EST - 2 years ago

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification

Champions Oncology Announces the Addition of Brady Davis as President

Oct 17, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology Announces the Addition of Brady Davis as President

Champions Oncology, Inc. (CSBR) Q1 2024 Earnings Call Transcript

Sep 15, 2023, 1:34 PM EDT - 2 years ago

Champions Oncology, Inc. (CSBR) Q1 2024 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $12.6 Million

Sep 13, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $12.6 Million

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023

Sep 11, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023

Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023

Aug 22, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023

Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies

Aug 1, 2023, 8:45 AM EDT - 2 years ago

Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies

Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Call Transcript

Jul 24, 2023, 6:34 PM EDT - 2 years ago

Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $13.1 Million

Jul 24, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $13.1 Million

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023

Jul 20, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023

Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development

Apr 17, 2023, 8:30 AM EDT - 3 years ago

Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development

OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 29 at 1:54 PM
$CSBR RSI: 69.16, MACD: 0.1474 Vol: 0.31, MA20: 6.95, MA50: 6.76 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Ned__ryerson
Ned__ryerson Jan. 28 at 4:03 AM
$CSBR up big. Volume was light. It wants to pop. Just looking for a reason.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 2 at 7:39 PM
$CSBR RSI: 54.55, MACD: 0.0801 Vol: 0.47, MA20: 6.73, MA50: 6.71 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Hemispheric
Hemispheric Dec. 26 at 12:25 PM
$CSBR Price action signals that reliability now matters more than headline momentum. Efficiency initiatives must translate into measurable productivity. Demonstrated durability would lengthen investor time horizons. Without validation, volatility will remain persistent.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 24 at 11:20 PM
$CSBR Share Price: $7.05 Contract Selected: May 15, 2026 $7.5 Calls Buy Zone: $0.77 – $0.95 Target Zone: $1.32 – $1.61 Potential Upside: 63% ROI Time to Expiration: 141 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Norisknoporsche
Norisknoporsche Dec. 16 at 8:23 AM
$CSBR Earnings yesterday was so bullish
0 · Reply
Delonche
Delonche Dec. 15 at 10:09 PM
$CSBR
0 · Reply
AOB1992
AOB1992 Dec. 15 at 9:22 PM
$CSBR https://www.stocktitan.net/news/CSBR/champions-oncology-reports-record-quarterly-service-revenue-of-14-9-1iivypwxl90n.html Looks like it's a beat!
0 · Reply
AOB1992
AOB1992 Dec. 15 at 9:05 PM
$CSBR bought this as an "earnings play" and it's up already, oh my
0 · Reply
Delonche
Delonche Dec. 15 at 8:45 PM
$CSBR
0 · Reply
Delonche
Delonche Dec. 15 at 8:42 PM
$CSBR
0 · Reply
Delonche
Delonche Dec. 15 at 8:28 PM
$CSBR it would be nice to pop 30% up
0 · Reply
topstockalerts
topstockalerts Dec. 15 at 8:23 PM
$CSBR setting up nicely.. 🏦
0 · Reply
Delonche
Delonche Dec. 15 at 8:11 PM
$CSBR
0 · Reply
Delonche
Delonche Dec. 15 at 8:06 PM
$CSBR
0 · Reply
Delonche
Delonche Dec. 15 at 7:48 PM
$CSBR
0 · Reply
Delonche
Delonche Dec. 15 at 7:08 PM
$CSBR
0 · Reply
VolcanicTrades
VolcanicTrades Dec. 15 at 1:11 AM
$CSBR
0 · Reply
Ned__ryerson
Ned__ryerson Dec. 14 at 1:28 PM
$CSBR earnings Monday. Not sure what is coming. Likely more of the same.
1 · Reply
RadioIsotope25
RadioIsotope25 Nov. 19 at 11:19 PM
$RADX Phase 3 starting 4th quarter 2006. Will be third largest radio imaging agent in the world and market cap is $45 million. While Lantheus and Telix trade at $3-5 billion valuations. $LNTH $CATX $CSBR $VNDA
0 · Reply
RadioIsotope25
RadioIsotope25 Nov. 10 at 8:01 PM
$CSBR Isotopes $NNE
0 · Reply